Your browser doesn't support javascript.
loading
Circulating tumor DNA clearance predicts prognosis across treatment regimen in a large real-world longitudinally monitored advanced non-small cell lung cancer cohort.
Song, Yong; Hu, Chengping; Xie, Zhanhong; Wu, Lin; Zhu, Zhengfei; Rao, Chuangzhou; Liu, Li; Chen, Yuan; Liang, Naixin; Chen, Jun; Hu, Chunhong; Yang, Nong; Hu, Jie; Zhao, Weixin; Tong, Gangling; Dong, Xiaorong; Zheng, Di; Jin, Meiling; Chen, Jianhua; Huang, Meijuan; He, Yong; Rosell, Rafael; Lippi, Giuseppe; Mino-Kenudson, Mari; Han-Zhang, Han; Mao, Xinru; Zhang, Lu; Liu, Hao; Field, John K; Chuai, Shannon; Ye, Junyi; Han, Yusheng; Lu, Shun.
Afiliação
  • Song Y; Department of Respiratory Medicine, Jinling Hospital, Nanjing University School of the Medicine, Nanjing 210002, China.
  • Hu C; Department of Respiratory Medicine, Xiangya Hospital, Central South University, Changsha 410008, China.
  • Xie Z; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China.
  • Wu L; Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013, China.
  • Zhu Z; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
  • Rao C; Department of Radiotherapy and Chemotherapy, Hwamei Hospital, University of Chinese Academy of Sciences, Ningbo 315010, China.
  • Liu L; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
  • Chen Y; Department of Medical Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
  • Liang N; Department of Thoracic Surgery, Peking Union Medical College Hospital Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100730, China.
  • Chen J; Department of Lung Cancer Surgery, Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin 300052, China.
  • Hu C; Department of Oncology, The Second Xiangya Hospital of Central South University, Changsha 410008, China.
  • Yang N; Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013, China.
  • Hu J; Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
  • Zhao W; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
  • Tong G; Department of Oncology, Peking University Shenzhen Hospital, Shenzhen 518036, China.
  • Dong X; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
  • Zheng D; Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai 200433, China.
  • Jin M; Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
  • Chen J; Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013, China.
  • Huang M; Department of Oncology, West China Hospital, Chengdu 610041, China.
  • He Y; Department of Respiratory Medicine, Daping Hospital, Army Medical University, Chongqing 400042, China.
  • Rosell R; Cancer Biology and Precision Medicine Program, Catalan Institute of Oncology, Germans Trias I Pujol Health Sciences Institute and Hospital Badalona, Barcelona, Spain.
  • Lippi G; Section of Clinical Biochemistry, University of Verona, Verona, Italy.
  • Mino-Kenudson M; Department of Pathology, Massachusetts General Hospital, Boston, USA.
  • Han-Zhang H; Burning Rock Biotech, Guangzhou 510300, China.
  • Mao X; Burning Rock Biotech, Guangzhou 510300, China.
  • Zhang L; Burning Rock Biotech, Guangzhou 510300, China.
  • Liu H; Burning Rock Biotech, Guangzhou 510300, China.
  • Field JK; Roy Castle Lung Cancer Research Program, The University of Liverpool, Department of Molecular and Clinical Cancer Medicine, Liverpool, UK.
  • Chuai S; Burning Rock Biotech, Guangzhou 510300, China.
  • Ye J; Burning Rock Biotech, Guangzhou 510300, China.
  • Han Y; Burning Rock Biotech, Guangzhou 510300, China.
  • Lu S; Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai 200030, China.
Transl Lung Cancer Res ; 9(2): 269-279, 2020 Apr.
Article em En | MEDLINE | ID: mdl-32420066

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Transl Lung Cancer Res Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Transl Lung Cancer Res Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China